Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025)

Cumberland Pharmaceuticals (CPIX) posted Acquisitions of $1.0 million for Q4 2025, up 68.33% sequentially from $611600.0 in Q3 2025.

Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025) Analysis & Trends

Cumberland Pharmaceuticals has reported Acquisitions for 3 years, with the latest figure at $1.0 million in Q4 2025.

Quarterly Acquisitions changed N/A year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, changed N/A from the prior year.
Acquisitions grew to $1.0 million in Q4 2025 per CPIX's latest filing, from $611600.0 in the prior quarter.
Over five years, Acquisitions peaked at $13.5 million in Q1 2022 and troughed at -$326262.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Cumberland Pharmaceuticals	114.68 Mn	110.82 Mn	-	-

Download Data